Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations

Journal of the American College of Cardiology

Volumn 38, Issue 2, 2001, Pages 315-321

  Maron, Barry J ^a   Niimura, Hideshi ^b   Casey, Susan A ^a   Soper, Marjorie K ^a   Wright, Gregory B ^c   Seidman, J G ^d   Seidman, Christine E ^d  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c Children's Heart Clinic   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN BINDING PROTEIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; GENE MUTATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; SARCOMERE; SCREENING;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; ELECTROCARDIOGRAPHY; FAMILY HEALTH; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PENETRANCE; PHENOTYPE; PROSPECTIVE STUDIES;

EID: 0034900986     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01386-9     Document Type: Article

References (28)

1. Hypertrophic cardiomyopathy: The importance of the site and the extent of hypertrophy. A review
2. Hypertrophic cardiomyopathy
3. Molecular basis of familial cardiomyopathies
4. Recent advances in the molecular genetics of hypertrophic cardiomyopathy
5. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy
6. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy
7. Mutations in the gene for human cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy
8. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy
9. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: Hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome
10. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients
11. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy
12. Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy
13. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
14. A discussion of nomenclature
15. Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood
16. Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes
17. Mutations in the cardiac myosin-binding protein C gene on chromosome 11 cause familial hypertrophic cardiomyopathy
18. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy
19. Systolic anterior motion of the posterior mitral leaflet: A previously unrecognized cause of dynamic subaortic obstruction in hypertrophic cardiomyopathy
20. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene
21. Sudden death due to troponin T mutations
22. Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy
23. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
24. Sudden death due to hypertrophic cardiomyopathy in the absence of increased left ventricular mass
25. Hypertrophic cardiomyopathy without hypertrophy: Two families with myocardial disarray in the absence of increased myocardial mass
26. 26th Bethesda Conference: Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities
27. The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy
28. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population